[RECOMMENDATIONS FOR CHANGING CARDIOVASCULAR SCREENING OF ATHLETES WHO ARE REQUIRED FOR PRE-PARTICIPATION SCREENING UNDER THE SPORTS LAW - A POSITION PAPER ON BEHALF OF THE ISRAEL HEART SOCIETY].


Journal

Harefuah
ISSN: 0017-7768
Titre abrégé: Harefuah
Pays: Israel
ID NLM: 0034351

Informations de publication

Date de publication:
Jul 2022
Historique:
entrez: 14 7 2022
pubmed: 15 7 2022
medline: 16 7 2022
Statut: ppublish

Résumé

For many years routine screening of athletes in Israel includes frequently performed ECGs and exercise tests that overload the system with questionable benefits. The purpose of the current document is to reevaluate the need for pre-participation testing and establish new evidence-based guidelines. It should be noted that our proposal for a change of approach relates only to subjects whose health questionnaire is normal, who do not have a family history of sudden and unexpected death at an early age, or a family history of hereditary heart disease and whose physical examination from a cardiovascular point of view is normal.

Identifiants

pubmed: 35833433

Types de publication

Guideline

Langues

heb

Sous-ensembles de citation

IM

Pagination

454-457

Auteurs

Michael Glikson (M)

Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel.

Yoav Michowitz (Y)

Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel.

Anat Milman (A)

Leviev Heart Institute, and Sports and Exercise Medicine Clinic, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ron Golan (R)

Cardiac Rehabilitation and Sports Medicine Institute, Cardiology Department, Ziv Medical Center, Zefat, Israel.

Dan Hadas (D)

Pediatric Cardiology, Shamir Medical Center, Zrifin, Israel.

Arik Wolak (A)

Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel.

Moti Haim (M)

Cardiology Department, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Shirit Kazum (S)

Cardiology Department Rabin Medical Center, Petach Tikva, Tel Aviv University, Sackler Faculty of Medicine.

Rami Fogelman (R)

Cardiology Institute. Schneider Children Medical Center of Israel.

Shmuel Fuchs (S)

Cardiology Institute, Shamir Medical Center.

Naama W Constantini (NW)

Heidi Rothberg Sport Medicine Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel.

Mickey Scheinowitz (M)

Department of Biomedical Engineering, Faculty of Engineering, and School for Public Health, Sackler Faculty of Medicine, Tel Aviv University.
Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Hashomer, Israel.

Gad Keren (G)

Assuta Medical Center.

Andre Keren (A)

Division of Cardiology, Hadassah-Hebrew University Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH